Search research articles
Contact Us
Filters
Showing results (601-610 of 751) with videos related to
Page
of 76
Sort By:
American Heart Journal
|
February 20, 2026
Design and rationale of RECOVER-AUTONOMIC: a randomized platform trial evaluating interventions for Long COVID postural orthostatic tachycardia syndrome
Marat Fudim, Peter Novak, Pam R Taub, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 5, 2026
Evaluation of the updated ABC-AF-bleeding score 2.0 in patients with atrial fibrillation treated with a direct oral anticoagulant or warfarin
Ziad Hijazi, Johan Lindbäck, Jonas Oldgren, et al.
European Journal of Heart Failure
|
February 14, 2015
Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme
Athar A Badar, Ana C Perez-Moreno, Nathaniel M Hawkins, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
December 28, 2020
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial
Raffaele De Caterina, Giuseppe Patti, Johan Westerbergh, et al.
American Heart Journal
|
June 7, 2016
A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale
Meena P Rao, Andrea O Ciobanu, Renato D Lopes, et al.
Journal of the American Heart Association
|
October 26, 2017
Impact of Regional Systems of Care on Disparities in Care Among Female and Black Patients Presenting With ST-Segment-Elevation Myocardial Infarction
Tomoya T Hinohara, Hussein R Al-Khalidi, Christopher B Fordyce, et al.
Circulation
|
February 16, 2006
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program
Eileen O'Meara, Tim Clayton, Margaret B McEntegart, et al.
Circulation
|
January 19, 2021
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
Ziad Hijazi, John H Alexander, Zhuokai Li, et al.
Circulation. Heart Failure
|
May 1, 2023
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial
Karola S Jering, Brian L Claggett, Marc A Pfeffer, et al.
American Heart Journal
|
September 24, 2017
Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF)
Dragos Vinereanu, Hussein R Al-Khalidi, Meena P Rao, et al.
Page
of 76
Search research articles
Search
Showing results (601-610 of 751) with videos related to
Sort By:
Page
of 76
American Heart Journal
|
February 20, 2026
Design and rationale of RECOVER-AUTONOMIC: a randomized platform trial evaluating interventions for Long COVID postural orthostatic tachycardia syndrome
Marat Fudim, Peter Novak, Pam R Taub, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 5, 2026
Evaluation of the updated ABC-AF-bleeding score 2.0 in patients with atrial fibrillation treated with a direct oral anticoagulant or warfarin
Ziad Hijazi, Johan Lindbäck, Jonas Oldgren, et al.
European Journal of Heart Failure
|
February 14, 2015
Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme
Athar A Badar, Ana C Perez-Moreno, Nathaniel M Hawkins, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
December 28, 2020
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial
Raffaele De Caterina, Giuseppe Patti, Johan Westerbergh, et al.
American Heart Journal
|
June 7, 2016
A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale
Meena P Rao, Andrea O Ciobanu, Renato D Lopes, et al.
Journal of the American Heart Association
|
October 26, 2017
Impact of Regional Systems of Care on Disparities in Care Among Female and Black Patients Presenting With ST-Segment-Elevation Myocardial Infarction
Tomoya T Hinohara, Hussein R Al-Khalidi, Christopher B Fordyce, et al.
Circulation
|
February 16, 2006
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program
Eileen O'Meara, Tim Clayton, Margaret B McEntegart, et al.
Circulation
|
January 19, 2021
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
Ziad Hijazi, John H Alexander, Zhuokai Li, et al.
Circulation. Heart Failure
|
May 1, 2023
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial
Karola S Jering, Brian L Claggett, Marc A Pfeffer, et al.
American Heart Journal
|
September 24, 2017
Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF)
Dragos Vinereanu, Hussein R Al-Khalidi, Meena P Rao, et al.
Page
of 76